TransTRACK, an innovative technology startup dedicated to transforming the logistics and transportation industry, has successfully raised an impressive $12 million in its latest funding round. This significant investment marks a crucial step towards achieving TransTRACK's vision of becoming the leading fleet operation optimizer and supply chain integrator in the market. With a mission to empower businesses to streamline their operations, reduce costs, and enhance sustainability, TransTRACK provides cutting-edge digitized solutions that can increase fleet productivity and utilization by up to 40%, while simultaneously decreasing overtime, fuel, and labor costs by 30%. The funds will be strategically deployed to further develop TransTRACK's suite of offerings, including its advanced Fleet Operation Optimizer, comprehensive fleet management system, and efficient Transportation Management software. These tools are designed to enhance delivery processes, alleviate truck congestion, and facilitate smooth loading and unloading, ultimately enabling companies to optimize their logistics and boost overall efficiency. Additionally, TransTRACK's platform provides complete visibility throughout the supply chain, fostering improved customer engagement and creating new revenue opportunities. This infusion of capital not only represents the confidence investors have in TransTRACK's vision but also positions the company for accelerated growth and deeper market penetration. With an unwavering commitment to driving productivity and facilitating business growth, TransTRACK is poised to revolutionize the logistics landscape, making it an exciting player to watch in the industry.

TransTRACK Secures $12 Million in Series A Funding to Revolutionize Logistics and Transportation Industry
Get the full TransTRACK company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
EarthOptics
EarthOptics is transforming how the world understands and manages soil. By combining next-generation sensors, advanced algorithms, and carbon analytics, we’re building the Soil Cloud—a powerful data platform that empowers farmers to sustainably optimize their operations, increase yields, and feed a growing global population. Our technology delivers high-resolution insights into soil properties at scale, making a positive impact on both environmental health and farm profitability.
$110.0M Series c
today

Otomato.xyz
Meet your Smart DeFi assistant. One setup, zero dashboards. Get hyper-targeted updates on your positions, starting with HyperEVM. ✨
$2.0M Seed
today

Waypoint Bio
Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.
$20.0M Series a
today

Crimson
Crimson’s IT recruitment services simplify the recruitment process, helping hiring managers find the best contract and permanent IT talent in established and emerging disciplines. Clients and candidates alike continue to choose Crimson because of three specific reasons: A commitment to keeping promises and delivering first time, supported by a £1M investment in relationship management technology. An unparalleled network and expert market insight from over 20 years’ sector experience. A world-beating level of friendly service borne out by a world-beating Net Promotor Score. Talk to us on 01675 466 477 and discover for yourself why candidates and hiring managers choose Crimson for their IT recruitment solutions.
$2.5M Seed
today

Asteromorph
We are a team of scientists and engineers working on building scientific superintelligence. Our discovery system - an orchestration of AI models designed to drive scientific progress as an independent architect - inspires breakthrough theses and develops them to robust statements with self-conducted experiments in both silicon and physical world.
$31.4M Seed
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Waypoint Bio United States | Series a | $20.0M | today |
| 2 | ![]() Default United States | Series a | $20.0M | today |
| 3 | ![]() Abstract United States | Series a | $59.0M | 1d ago |
| 4 | ![]() Pacifico Biolabs Germany | Series a | €7.0M | 1d ago |
| 5 | ![]() Secretome Therapeutics United States | Series a | $30.0M | 1d ago |



